Ticker / mid cap

DAWN

Day One Biopharmaceuticals Inc
1
Contracts
$4.1M
Total Value

Stock Metrics

9.2%
Short % Float
5.4d to cover · Moderate squeeze
83.5%
Inst % Float
216 holders
BlackRock, Inc.
Top Holder
71.3M sh
Public Float
16/100
Dilution Score
Low
34 mo
Cash Runway
Verified regulatory filings & proprietary analysis.

Fleet Intelligence

Dilution Risk
16/100
LOW
Inst: 83.49% · Top: BlackRock, Inc.
Biotech Analytics
D
Pediatric Oncology
39.59
Squeeze risk: MODERATEBiotech Grade: D

Biotech Analytics D Pediatric Oncology · score 39.59

Insider Buying0
Publications100
Dilution Risk16
Clinical Trials71
Short Interest30

Contracts

DateSourceTitleAwardeeValueScore
2025-09-22usaspending47PF0025F0849DAWN INCORPORATED$4.1M0.1

News Signals

D-Orbit, Firefly And Katalyst Nab Deorbit-As-A-Service Awards From DIU And SDA Fdefense_daily 5d
Engel & Völkers adds high-producing Silicon Valley agenthousingwire 6d